| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Gastric Surgery Division (EB, YY), Shizuoka Cancer Center, Shizuoka, Japan; and the Second Department of Surgery (EB, YY, KT, SF, TF, KM), School of Medicine, Kanazawa University, Kanazawa, Japan.
Correspondence: Address correspondence and reprint requests to: Yutaka Yonemura, MD, PhD, Shizuoka Cancer Center, Gastric Surgery Division, 1007, Shimonagakubo, Nagaizumichou, Suntougun, Ishizuoka, 411-8777, Japan; Fax: 55-989-5783, E-mail: y.yonemura{at}scchr.jp
Background: The purpose of this study was to clarify the outcome of the ratio of the metastatic lymph nodes (RML) in gastric cancer patients.
Methods: The postoperative survival of 650 patients with gastric cancer who underwent D2 curative gastrectomy was analyzed with regard to the RML. The location, number, and RML in the N1 station and in all (N1 and N2) stations were analyzed. These data were compared from the viewpoints of staging accuracy and patient survival.
Results: The RML was classified as follows: RML 0, no involvement; RML 1, 0 to .1; RML 2, .1 to .25; and RML 3,
.25. The 5-year survival rates stratified by RML were RML 0, 86%; RML 1, 68%; RML 2, 35%; and RML 3, 16%. Cox model identified all methods of classifying lymph node metastases as independent prognostic indicators in each calculation. However, a second Cox regression revealed that RML was the only independent prognostic factor among the three methods (P < .001). Stage migration was present in 35 cases (15%) when the number was considered. However, only 15 cases (7%) were underdiagnosed when RML was used.
Conclusions: RML is a useful classification of patients with gastric cancer. It may prevent the phenomenon of stage migration.
Key Words: Gastric cancer Ratio of lymph node metastasis "Will Rogers" phenomenon Multivariate analysis
This article has been cited by other articles:
![]() |
Z. Sun, G.-L. Zhu, C. Lu, P.-T. Guo, B.-J. Huang, K. Li, Y. Xu, D.-M. Li, Z.-N. Wang, and H.-M. Xu The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients Ann. Onc., May 1, 2009; 20(5): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peng, Y. Xu, Z. Guan, J. Zhu, M. Wang, G. Cai, W. Sheng, and S. Cai Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer Ann. Surg. Oncol., November 1, 2008; 15(11): 3118 - 3123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Falconi, S. Crippa, I. Dominguez, G. Barugola, P. Capelli, S. Marcucci, S. Beghelli, A. Scarpa, C. Bassi, and P. Pederzoli Prognostic Relevance of Lymph Node Ratio and Number of Resected Nodes after Curative Resection of Ampulla of Vater Carcinoma Ann. Surg. Oncol., November 1, 2008; 15(11): 3178 - 3186. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J.-J. Wang, and F. Wan A Common Misuse of Stepwise Regression in Studies of Ratio of Metastatic Lymph Nodes for Gastric Cancer Ann. Surg. Oncol., June 1, 2008; 15(6): 1805 - 1806. [Full Text] [PDF] |
||||
![]() |
M. B. Slidell, D. C. Chang, J. L. Cameron, C. Wolfgang, J. M. Herman, R. D. Schulick, M. A. Choti, and T. M. Pawlik Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis Ann. Surg. Oncol., January 1, 2008; 15(1): 165 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lee, H.-J. Choi, K.-J. Park, J.-S. Shin, H.-C. Kwon, M.-S. Roh, and C. Kim Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma Ann. Surg. Oncol., May 1, 2007; 14(5): 1712 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pedrazzani, Prof. G. deManzoni, D. Marrelli, S. Giacopuzzi, G. Corso, M. Bernini, and Prof. F. Roviello Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System Ann. Surg. Oncol., February 1, 2007; 14(2): 299 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Cheong, W. J. Hyung, J. G. Shen, C. Song, J. Kim, S. H. Choi, and S. H. Noh The N Ratio Predicts Recurrence and Poor Prognosis in Patients With Node-Positive Early Gastric Cancer Ann. Surg. Oncol., March 1, 2006; 13(3): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Berger, E. R. Sigurdson, T. LeVoyer, A. Hanlon, R. J. Mayer, J. S. Macdonald, P. J. Catalano, and D. G. Haller Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes J. Clin. Oncol., December 1, 2005; 23(34): 8706 - 8712. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bouche, M. Ychou, P. Burtin, L. Bedenne, M. Ducreux, G. Lebreton, J. Baulieux, B. Nordlinger, C. Martin, J. F. Seitz, et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801) Ann. Onc., September 1, 2005; 16(9): 1488 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. McKee and M. C. Posner The Staging of Gastric Cancer: Nothing Novel but Perhaps Better Ann. Surg. Oncol., November 1, 2003; 10(9): 1005 - 1006. [Full Text] [PDF] |
||||
![]() |
D. Nitti, A. Marchet, M. Olivieri, A. Ambrosi, R. Mencarelli, C. Belluco, and M. Lise Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience Ann. Surg. Oncol., November 1, 2003; 10(9): 1077 - 1085. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |